Manila Times Business
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related change in adults and pediatric patients.FET-PET imaging is recommended in international clinical practice guidelines, including NCCN Guidelines®.Pixclara expands Telix's industry-leading Precision Medicine business and reinforces the Company's leadership in diagnostics and targete
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
FITSTOP Global Games Set to Bring 1,000 Athletes to Brisbane for Major Functional Fitness Showdown
1h ago
MVP Ventures Deepens Ties With South Korean Investor Community as Managing Partner Weston Moyer Visits Seoul
1h ago
OTC Markets Group Announces Market Data Agreement With CITIC Securities Brokerage (HK) Limited
1h ago
Baker Hughes and Venture Global Advance Next Phase of U.S. Gas Infrastructure Growth
1h ago